결핵 진료지침

11. Song S, Jeon D, Kim JW, Kim YD, Kim SP, Cho JS, et al. Performance of confirmatory interferon-γ release assays in school TB outbreaks. Chest 2012;141:983-8.
12. Kim HJ, Lee GH, Ryoo S, Oh SY, Lee JB, Kim JH, et al. Role of confirmatory interferon- gamma release assays in school outbreaks of tuberculosis in South Korea. Int J Tuberc Lung Dis 2015;19:576-81.
13. Banaei N, Gaur RL, Pai M. Interferon gamma release assays for latent tuberculosis: what are the sources of variability? J Clin Microbiol. 2016;54:845-50.
14. Centers for Disease Control and Prevention. Guidelines for treatment of latent tuberculosis infection: recommendations from the national tuberculosis controllers association and CDC; 2020.
15. World Health Organization. WHO consolidated guidelines on tuberculosis. Module 1: prevention-tuberculosis preventive treatment; 2020.
16. Sterling TR, Villarino ME, Borisov AS, Shang N, Gordin F, Bliven-Sizemore E, et al. Three months of rifapentine and isoniazid for latent tuberculosis infection. N Engl J Med. 2011;365:2155-66.
17. Centers for Disease Control and Prevention. Latent tuberculosis infection: a guide for primary health care providers; 2013.
18. Centers for Disease Control and Prevention. Core Curriculum on Tuberculosis; What the Clinician Should Know, 7th Edition; 2021.

VII. 소아청소년 결핵 <PAGE>271